Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: design and baseline characteristics of SOUL, a randomized trial
Tirzepatide's ongoing SURPASS-CVOT trial will provide similar data
Accordingly, mechanistic interpretations should not be construed as confirmed clinical mechanisms but as explanatory frameworks requiring validation in mechanistic human studies
195.00 For research use only Not for human or animal use Our Retatrutide 40mg Pen is a research peptide developed for scientific investigation into metabolic signalling, appetite pathways and body weight regulation
Tirzepatide (Mounjaro) A cutting-edge GLP-1 medication with even greater weight loss effects by enhancing insulin sensitivity and reducing hunger
FIGURE 1 2 Defining underexplored peptidereceptor systems In the context of peptide drug discovery, the term underexplored is often used imprecisely to denote novelty, obscurity, or a lack of published literature